A study in mice may have identified a way to help overcome resistance to targeted cancer drugs known as PI3K inhibitors. The approach appears to work by reducing insulin levels in patients receiving these drugs.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2OOIQE6